| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.006 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.26 | 0.0002 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.06 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 0.07 |